POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.
High Impact

Congressional Hearing on the Trump Administration's Drug Crisis Response

Original title: TRUMP ADMINISTRATION'S RESPONSE TO THE DRUG CRISIS

Record date · January 1, 2019

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

The House Committee on Oversight and Reform held a hearing on March 7, 2019, to evaluate the federal government's strategy for addressing the national drug overdose crisis. The session included testimony from federal officials and experts regarding the scope of the epidemic and the effectiveness of current policy responses.

Why it matters

This hearing serves as a formal oversight mechanism to review federal drug policy and the allocation of resources for the Office of National Drug Control Policy, which impacts national public health strategies and funding for local drug trafficking task forces.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Office of National Drug Control Policy

The agency's policies and funding were subject to congressional review and oversight during this hearing.

Directly affected

General Public

The hearing addresses national public health strategies regarding drug overdoses, which impact healthcare and law enforcement services nationwide.

Key Facts

  • The hearing took place on March 7, 2019, in the Rayburn House Office Building.
  • In 2017, more than 70,000 people died from drug overdoses in the United States.
  • The committee previously passed bipartisan legislation to reauthorize the Office of National Drug Control Policy.
  • The hearing included testimony from the Office of National Drug Control Policy, the Government Accountability Office, and the Houston High Intensity Drug Trafficking Area.
Show all 5 facts
  • Several documents were entered into the record, including the 2018 Houston HIDTA Threat Assessment Report and various articles on the opioid crisis.

Frequently Asked Questions

What was the purpose of this hearing?
The purpose was to review the Trump Administration's response to the national drug crisis and hear testimony from key policy and oversight officials.
Who testified at the hearing?
Witnesses included James W. Carroll, Jr. (Office of National Drug Control Policy), Triana McNeil (Government Accountability Office), and Mike McDaniel (Houston High Intensity Drug Trafficking Area).

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Bipartisan focus on drug policy

The hearing highlights a rare instance of bipartisan cooperation in the 116th Congress regarding the reauthorization of the Office of National Drug Control Policy.

Connected Entities

James W. Carroll, Jr., House Committee on Oversight and Reform, Elijah E. Cummings and 3 more
PersonJames W. Carroll, Jr.“Director of the Office of National Drug Control Policy”Map →
OrganizationHouse Committee on Oversight and Reform“Congressional committee conducting the hearing”Map →
PersonElijah E. Cummings“Chairman of the House Committee on Oversight and Reform”Map →
PersonMike McDaniel“Director, Houston High Intensity Drug Trafficking Area”Map →
PersonChris Christie“Former Governor of New Jersey and commission chair”Map →
PersonTriana McNeil“Acting Director, Strategic Issues, Government Accountability Office”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record